# Regal Healthcare Capital Partners

Regal Healthcare Capital Partners is a Private Equity based in New York, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** One Penn Plaza, Suite 4610, New York, NY 10119, United States
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** www.regalhcp.com
- **LinkedIn:** https://www.linkedin.com/company/regal-healthcare-capital-partners

## Regulatory record

- **Reports private funds:** No

## About

Regal Healthcare Capital Partners is a New York-based healthcare private equity firm focused exclusively on investments in healthcare services companies. It provides healthcare entrepreneurs with the strategic, financial, and operational value-add of deeply specialized growth partners. The firm targets companies with revenue of $20-100M and EBITDA of $2-10M, with typical equity investments of $30-70M.

## Sectors

- Healthcare Services

## People

- David Kim — Co-Founder and General Partner
- Jon Santemma — Co-Founder and General Partner

## Questions

### Who runs investment decisions at Regal Healthcare Capital Partners?

Investment decisions are made by Co-Founders and General Partners Dr. David Kim and Jon Santemma. Kim is a board-certified emergency physician and serial healthcare entrepreneur who co-founded CityMD, Dental365, and Progressive Emergency Physicians; Santemma was Global Head of Healthcare Investment Banking at Jefferies from 2009 to 2018 and previously ran healthcare services coverage at UBS.

### How does Regal source proprietary deal flow?

Regal's sourcing model leans on the clinical and entrepreneurial networks of its physician-operator co-founder. With three prior exits as a founder and an active role on the attending staff at Northwell Health, Kim accesses a pipeline of physician-led, multi-site businesses that sit below the radar of larger healthcare private equity platforms.

### Does Regal participate in fund commitments or only direct deals?

The firm's public materials describe direct control growth equity and buyout investments. No information on fund-of-fund commitments or LP allocations to external managers has been disclosed.

### Which sectors does Regal explicitly avoid?

Regal concentrates exclusively on healthcare services and has not disclosed investments outside that vertical. The website identifies no exposure to medical devices, biopharma, health-tech SaaS, or non-healthcare sectors.

## Related profiles

- [Regal Funds Management](https://altss.com/profile/regal-funds-management)
- [Regal Wealth Group](https://altss.com/profile/regal-wealth-group)

---

Last updated: 2026-08-11T15:07:57.118Z

Canonical page: https://altss.com/profile/regal-healthcare-capital-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology